Middeldorp S - Search Results

1

The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden.

Middeldorp S, Libourel EJ, Hamulyák K, Van der Meer J, Büller HR. Middeldorp S, et al. Br J Haematol. 2001 May;113(2):553-5. doi: 10.1046/j.1365-2141.2001.02766.x. Br J Haematol. 2001. PMID: 11380431 Free article.

2

The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis.

Middeldorp S, Henkens CM, Koopman MM, van Pampus EC, Hamulyák K, van der Meer J, Prins MH, Büller HR. Middeldorp S, et al. Ann Intern Med. 1998 Jan 1;128(1):15-20. doi: 10.7326/0003-4819-128-1-199801010-00003. Ann Intern Med. 1998. PMID: 9424976

3

Factor V:Q506 mutation-resistance to activated protein C (APC): clinical implications with respect to family screening.

Middeldorp S, van der Meer J. Middeldorp S, et al. Semin Thromb Hemost. 1998;24(4):363-6. doi: 10.1055/s-2007-996024. Semin Thromb Hemost. 1998. PMID: 9763353 Review.

4

Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism.

Levi M, Middeldorp S, Büller HR. Levi M, et al. Among authors: middeldorp s. Cardiovasc Res. 1999 Jan;41(1):21-4. doi: 10.1016/s0008-6363(98)00210-7. Cardiovasc Res. 1999. PMID: 10325950 No abstract available.

5

Increased risk for fetal loss in carriers of the factor V Leiden mutation.

Meinardi JR, Middeldorp S, de Kam PJ, Koopman MM, van Pampus EC, Hamulyák K, Prins MH, Büller HR, van der Meer J. Meinardi JR, et al. Among authors: middeldorp s. Ann Intern Med. 1999 May 4;130(9):736-9. doi: 10.7326/0003-4819-130-9-199905040-00013. Ann Intern Med. 1999. PMID: 10357692

6

Double-homozygosity for factor V Leiden and the prothrombin gene G20210A variant in a young patient with idiopathic venous thrombosis.

Mainardi JR, Pelsma PM, Koning H, van der Meer J, Middeldorp S, Büller HR, Hamulyák K. Mainardi JR, et al. Among authors: middeldorp s. Blood. 1999 Sep 1;94(5):1828-9. Blood. 1999. PMID: 10507841 Free article. No abstract available.

7

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.

Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Büller HR, Prins MH, Tans G. Rosing J, et al. Among authors: middeldorp s. Lancet. 1999 Dec 11;354(9195):2036-40. doi: 10.1016/s0140-6736(99)06092-4. Lancet. 1999. PMID: 10636369 Clinical Trial.

8

Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination.

Bijsterveld NR, Middeldorp S, Berends F, Büller HR. Bijsterveld NR, et al. Among authors: middeldorp s. J Thromb Thrombolysis. 2000 Apr;9(3):263-9. doi: 10.1023/a:1018722829498. J Thromb Thrombolysis. 2000. PMID: 10728026

9

Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.

Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR. Middeldorp S, et al. Thromb Haemost. 2000 Jul;84(1):4-8. Thromb Haemost. 2000. PMID: 10928461 Clinical Trial.

10

Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.

Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN. Meijers JC, et al. Among authors: middeldorp s. Thromb Haemost. 2000 Jul;84(1):9-14. Thromb Haemost. 2000. PMID: 10928462 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters